Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Using credit card points for travel can transform your journeys. Explore our guide to make the most of your points for unforgettable trips.
19,769 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A single, powerful driver could unlock a dramatic March for Netflix. Learn the core monetization lever and what inves...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
February layoffs slowed to 48,307, down sharply from January and far below last year's level. Analysts warn volatilit...
A single day shows $31.6m ethereum leaves exchanges, pushing reserves to multi-year lows and reigniting bets on a pot...
The chatter around prediction markets booming is loud, but this guide helps you focus on three AI stocks with real up...
Learn the core ideas behind a monster stock hold next five years and how patient investors can use a disciplined plan...
Visa sits at the center of a rising wave of short bets, even as it preserves a cash-generating moat. The latest data ...
A leading LNG stock jumped 32% this stock year, investor took profits, and a massive exit followed. Here’s how to und...
As 2026 AI demand shifts, investors weigh TSMC and AMD on who can sustain capacity, pricing power, and growth. This p...
Kraft Heinz trimmed guidance after a challenging quarter, McCormick posted steady growth with margin pressure, and Ho...
A fresh round of chatter around meta’s layoff rumor coming is rattling investors, with analysts weighing how a potent...